Gain Therapeutics Q3 EPS $(0.07) Beats $(0.12) Estimate
Benzinga Newsdesk 5 hours ago
NewsEarningsEarnings Beats
Gain Therapeutics (NASDAQ:GANX) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.12) by 41.67 percent. This is a 53.33 percent increase over losses of $(0.15) per share
Gain Therapeutics (NASDAQ:GANX) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.12) by 41.67 percent. This is a 53.33 percent increase over losses of $(0.15) per share from the same period last year.